The compounding pharmaceutical industry is subject to numerous requirements to ensure the safety of patients. This case study highlights Fagron Sterile Services, an FDA-registered 503B compounding facility, and its journey in implementing Endosafe® rapid bacterial endotoxin testing, and Accugenix® microbial identification to reduce human error, increase operational efficiency, and ultimately, save their organization time and money.